Avon Technologies PLC (LSE:AVON) reported a strong start to its 2026 financial year, with its Avon Protection division delivering a record first quarter driven by sustained demand for chemical, biological, radiological and nuclear (CBRN) protection equipment. The update was released ahead of the group’s Annual General Meeting, held at its Melksham site, and points to solid trading momentum across the business at the outset of the year.
Performance at Team Wendy was more subdued in the quarter, reflecting delays linked to the recent U.S. government shutdown, which slowed product testing and deliveries. Despite this, the group reiterated its full-year guidance, indicating confidence that the disruption will not have a lasting impact on overall FY26 expectations. Management noted that margins at Team Wendy were also affected by planned increases in investment ahead of higher production rates expected to come through from the second quarter, with these effects described as temporary.
Chief executive Jos Sclater said the group’s focus on continuous improvement and operational discipline is translating into a more resilient and sustainable business, while acknowledging that further efficiency gains are still required at the Cleveland facility. He added that, having stabilised and reshaped the group over the past three years, Avon is now moving into a more growth-oriented phase of its strategy, supported by increased investment in key programmes and new products. The company said it remains on track to meet, or potentially exceed, its FY26 financial targets.
More about Avon Technologies PLC
Avon Technologies PLC is a UK-based defence and protective equipment group supplying advanced personal protection systems to military, law enforcement and first responder customers worldwide. Through its Avon Protection and Team Wendy brands, the company provides CBRN respiratory equipment, helmets and related protection solutions, with a strategic focus on operational excellence, product innovation and expanding addressable markets.
Leave a Reply